Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Abstract

Renal cancer is the 14th most common malignancy worldwide, with >430 000 new cases diagnosed in 2020.1 The incidence varies geographically, with higher incidence in Europe and North America. Renal cell carcinoma (RCC) accounts for ∼90% of all renal cancers.1-3